Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance
Parsons, J Kellogg, Pinto, Peter A., Parnes, Howard L., Pavlovich, Christian P., Uchio, Edward M., Nguyen, Mike Minh, Kim, Hyung Lae, Gulley, James L., Sater, Houssein Abdul, Jamieson, Christina, Hsu, Chiu-Hsieh, Wojtowicz, Malgorzata E., Schlom, Jeffrey, Donahue, Renee Nicole, Centuori, Sara, Bailey, Shania, Bauman, Julie E., Chow, H H
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article